Currently out of the existing stock ratings of Michael Cherny, 121 are a BUY (56.28%), 65 are a HOLD (30.23%), 29 are a SELL (13.49%).

Michael Cherny

Work Performance Price Targets & Ratings Chart

Analyst Michael Cherny, currently employed at LEERINK, carries an average stock price target met ratio of 59.07% that have a potential upside of 25.97% achieved within 257 days.

Michael Cherny’s has documented 432 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Financial Services, Consumer Defensive sectors.

Most recent stock forecast was given on NVST, Envista Holdings Corp at 29-Apr-2025.

Wall Street Analyst Michael Cherny

Analyst best performing recommendations are on GDRX (GOODRX HOLDINGS ).
The best stock recommendation documented was for TDOC (TELADOC) at 7/6/2022. The price target of $42 was fulfilled within 1 day with a profit of $3.19 (8.22%) receiving and performance score of 82.2.

Average potential price target upside

of $57.28 (17.3%) on MCK (MCKESSON).
of $43.27 (19.26%) on COR (CENCORA).
of $27.05 (48.43%) on CVS (CVS HEALTH CORP).

ABC AmerisourceBergen ACCD Accolade CAH Cardinal Health CERN Cerner Corp CNVY Convey Holding Parent CVS CVS Health Corp GOCO GoHealth HSIC Henry Schein MCK McKesson NVST Envista Holdings Corp OMI Owens & Minor PDCO Patterson Companies PGNY Progyny RCM R1 RCM SGFY Signify Health TDOC Teladoc WBA Walgreens Boots Alliance PINC Premier ATHN athenahealth XRAY Dentsply Sirona HIMS Hims Hers Health SONX Sonendo MDRX Allscripts Healthcare Solutions TRHC Tabula Rasa HealthCare GDRX Goodrx Holdings ALGN Align Technology COR Cencora DGX Quest Diagnostics ICLR ICON PLC IQV IQVIA Holdings LH Laboratory of America Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Charles Rhyee (LAKE STREET)